MCL1 and hematopoietic and lymphoid cell neoplasm: In the same study, 2-DG rapidly affected steady-state MCL-1 levels, sensitizing human hematopoietic tumor cell lines to ABT-737, a nonselective BCL-2/BCL-XL-antagonizing BH3 mimetic.